PMID: 11920518Mar 29, 2002Paper

Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy

Cancer
Roy S Herbst, Dong M Shin

Abstract

Traditional cytotoxic approaches to tumor management are associated with efficacy and toxicity limitations. Blockade of the epidermal growth factor receptor (EGFR) and its ligands is a novel approach to the treatment of human tumors that offers a noncytotoxic alternative to cancer treatment. An English-language literature search was conducted to identify studies assessing the in vitro and in vivo effects of EGFR blockade with an emphasis on approaches that use monoclonal antibody therapy. The EGF pathway regulates normal cellular processes and appears to be correlated with the development of malignancy. Approximately 30% of human tumors express EGFR, which has been reported to be correlated with poor prognosis and diminished disease-free and overall survival in selected tumor types. A number of anti-EGFR monoclonal antibodies have been developed, which currently are undergoing clinical trials in humans. Effective anti-EGFR monoclonal antibodies compete with endogenous ligands, primarily EGF and transforming growth factor-alpha, for receptor ligand-binding sites. Binding to EGFR blocks critical signaling pathways and interferes with the growth of tumors expressing EGFR. Anti-EGFR monoclonal antibodies that currently are under st...Continue Reading

References

Jan 1, 1979·Annual Review of Biochemistry·G Carpenter, S Cohen
Jan 1, 1992·Progress in Growth Factor Research·S A Prigent, N R Lemoine
Jan 1, 1991·Cancer Investigation·B W EnnisR B Dickson
Dec 1, 1989·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·E M Rosen, I D Goldberg
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A F LoBuglioM B Khazaeli
Jan 1, 1987·Annual Review of Biochemistry·G Carpenter
Jan 1, 1988·Annual Review of Biochemistry·Y Yarden, A Ullrich
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T KawamotoJ Mendelsohn
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R SeshadriP Kitchen
Feb 10, 1994·Journal of Immunological Methods·R J Owens, R J Young
Aug 18, 1993·Journal of the National Cancer Institute·J BaselgaJ Mendelsohn
Jan 21, 1993·International Journal of Cancer. Journal International Du Cancer·O EngebraatenO D Laerum
Jun 1, 1993·Cancer Immunology, Immunotherapy : CII·K ShitaraN Hanai
Jan 1, 1995·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·H BierP Stasiecki
Nov 1, 1995·Glia·V P Collins
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Jan 1, 1996·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·T ShibataM Hosokawa
Apr 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G StragliottoJ Y Delattre
Jul 1, 1996·The Journal of Pathology·S B FoxA L Harris
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J T PriceN E Haites
Dec 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F Tannock
Jan 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·H NiikuraA Yajima
Nov 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S FujinoA Mori
Nov 1, 1996·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·M PrewettN I Goldstein

❮ Previous
Next ❯

Citations

Dec 11, 2002·Expert Opinion on Therapeutic Targets·John T Lee, James A McCubrey
Jun 5, 2003·Expert Opinion on Investigational Drugs·Rita NahtaFrancisco J Esteva
Aug 28, 2003·Current Treatment Options in Oncology·Sharlene GillRichard M Goldberg
Aug 10, 2004·Cancer Science·Yuji HinodaKohzoh Imai
Oct 29, 2004·Current Treatment Options in Oncology·L Burt Nabors
Aug 9, 2006·International Journal of Cancer. Journal International Du Cancer·Daniel VallböhmerHeinz-Josef Lenz
Dec 13, 2006·Anti-cancer Drugs·Michael Cohenuram, Muhammad Wasif Saif
Dec 15, 2006·World Journal of Gastroenterology : WJG·Jyoti NautiyalAdhip P N Majumdar
Oct 27, 2007·Lasers in Surgery and Medicine·Xiaohua HuangMostafa A El-Sayed
Jan 1, 2008·The Oncologist·Christian WidakowichAhmad Awada
Mar 28, 2008·Expert Review of Molecular Diagnostics·Christian Ensinger, William Sterlacci
Jun 24, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Susan Goodin
Jun 12, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Arlhee DiazEnrique Montero
Feb 3, 2011·World Journal of Surgery·Courtney J BalentineF Charles Brunicardi
Aug 10, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M SakiH P Rodemann
Mar 19, 2013·Journal of Healthcare Engineering·Supang Khondee, Thomas D Wang
May 16, 2014·Nanomedicine·Rajaletchumy Veloo KuttySi-Shen Feng
Apr 3, 2016·Journal of Translational Medicine·Glenwood D GossJim Dimitroulakos
Nov 3, 2016·Cellular and Molecular Life Sciences : CMLS·Ruud WeijerMichal Heger
Apr 27, 2017·Macromolecular Bioscience·Claudia Battistella, Harm-Anton Klok
Mar 30, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·O KöstekB Erdoğan
Apr 27, 2019·Journal of Hematology & Oncology·Chao ZhangWen-Zhao Zhong
Oct 18, 2019·Current Molecular Pharmacology·Samira BahramiAmirhossein Sahebkar
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Dec 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Terrance G JohnsAndrew M Scott
Sep 1, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Harri SihtoHeikki Joensuu
Nov 3, 2005·Expert Opinion on Emerging Drugs·Philip E Shaheen, Ronald M Bukowski
Jul 14, 2007·Expert Review of Anticancer Therapy·Jaume CapdevilaJosep Tabernero
Sep 12, 2008·The New England Journal of Medicine·Robert I Haddad, Dong M Shin
Jan 26, 2010·Expert Opinion on Investigational Drugs·Muhammad W Saif

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.